已发表论文

miR-125a-5p 通过靶向 TAZ 抑制结直肠癌细胞上皮 - 间质转化、侵袭和迁移

 

Authors Tang L, Zhou L, Wu S, Shi X, Jiang G, Niu S, Ding D

Received 17 October 2018

Accepted for publication 26 February 2019

Published 7 May 2019 Volume 2019:12 Pages 3481—3489

DOI https://doi.org/10.2147/OTT.S191247

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Ms Justinn Cochran

Peer reviewer comments 4

Editor who approved publication: Dr Gaetano Romano

Background: miR-125a-5p regulated biological processes in various types of cancer, including colorectal cancer (CRC). TAZ, a vital transcriptional coactivators of the Hippo pathway, was found to be overexpressed in various cancers.
Objectives: This study aims to study the effect of miR-125a-5p on the progression of CRC by regulating TAZ expression.
Methods: In this study, miR-125a-5p and TAZ expression in CRC tissue and cell lines were detected by real-time polymerase chain reaction (RT-PCR). Luciferase reporter assay was applied to detect whether TAZ was a target of miR-125a-5p. Cell migration and invasion were detected in vitro by wound-healing assay and cell invasion assay. Western blot was used to detect the expression of epithelial-mesenchymal transition (EMT)-related proteins.
Findings: The results revealed downregulation of miR-125a-5p, as well as upregulation of TAZ in CRC tissue and cell lines. TAZ was identified as a direct target of miR-125a-5p, and its expression was negatively regulated by miR-125a-5p in CRC cell lines. The functional studies revealed that overexpression of miR-125a-5p inhibited the migration, invasion and EMT of CRC cells, while upregulation of TAZ reversed the inhibitory effect caused by miR-125a-5p.
Conclusion: Our data suggest that miR-125a-5p inhibits CRC cell migration, invasion and EMT by targeting TAZ. These results suggest that miR-125a-5p serves as a potential therapeutic biomarker for CRC patients.
Keywords: miR-125a-5p, TAZ, colorectal cancer, epithelial–mesenchymal transition, migration, invasion




Figure 1 miR-125a-5p was downregulated in CRC tissues and cell lines...